Chemed Boosts Stock Buyback Authorization by $300M
Dow Jones
Feb 14
By Elias Schisgall
Chemed board of directors approved an additional $300 million for stock buybacks.
The company, which owns a hospice care provider and a plumbing and drain cleaning business, said Friday its board had authorized the new buyback capacity under Chemed's existing share repurchase program.
Chemed said share repurchases would be funded from a combination of cash and the company's revolving credit facility.
Write to Elias Schisgall at elias.schisgall@wsj.com
(END) Dow Jones Newswires
February 13, 2026 13:47 ET (18:47 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.